Vir Biotechnology, Inc.
VIR
$5.09
-$0.325-6.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -30.28% | -40.53% | -46.10% | -37.69% | -48.90% |
| Total Receivables | 31.71% | -56.03% | -31.17% | -44.62% | -77.09% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -19.40% | 4.09% | -26.96% | -53.90% | -42.41% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 561.05% | 573.69% | 579.13% | 5.95% | 21.70% |
| Total Current Assets | -23.15% | -34.36% | -40.81% | -38.05% | -48.57% |
|
|
|||||
| Total Current Assets | -23.15% | -34.36% | -40.81% | -38.05% | -48.57% |
| Net Property, Plant & Equipment | -26.15% | -26.52% | -26.96% | -28.33% | -12.11% |
| Long-term Investments | 0.00% | 0.00% | 0.01% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.01% | 0.00% | 0.00% |
| Total Other Intangibles | -64.07% | -64.02% | -24.35% | -26.15% | -31.14% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -35.89% | -2.32% | -17.63% | -16.69% | -18.76% |
| Total Assets | -27.10% | -27.11% | -26.73% | -25.59% | -32.71% |
|
|
|||||
| Total Accounts Payable | -47.64% | -19.78% | 101.41% | -64.50% | -41.44% |
| Total Accrued Expenses | 61.65% | -19.01% | -39.28% | -70.05% | -87.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -33.48% | -39.75% | 43.16% | 44.02% | 63.91% |
| Total Finance Division Other Current Liabilities | 80.96% | -45.59% | -37.62% | -37.30% | -44.01% |
| Total Other Current Liabilities | 80.96% | -45.59% | -37.62% | -37.30% | -44.01% |
| Total Current Liabilities | 45.94% | -31.78% | -29.01% | -57.27% | -80.62% |
|
|
|||||
| Total Current Liabilities | 45.94% | -31.78% | -29.01% | -57.27% | -80.62% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -19.24% | -19.28% | -18.15% | -19.35% | -10.12% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -11.35% | -7.47% | -48.08% | -50.73% | -50.93% |
| Total Liabilities | 7.01% | -24.45% | -30.33% | -45.61% | -64.52% |
|
|
|||||
| Common Stock & APIC | 3.98% | 4.54% | 5.33% | 6.01% | 6.63% |
| Retained Earnings | -190.58% | -219.47% | -437.70% | -1,162.22% | -228.25% |
| Treasury Stock & Other | 17.61% | -110.67% | 159.32% | 0.83% | 25.54% |
| Total Common Equity | -32.54% | -27.66% | -25.93% | -20.80% | -21.48% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -32.54% | -27.66% | -25.93% | -20.80% | -21.48% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -32.54% | -27.66% | -25.93% | -20.80% | -21.49% |
|
|
|||||